Cetera Investment Advisers’s Exact Sciences EXAS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.58M | Buy |
105,006
+16,773
| +19% | +$891K | 0.01% | 1124 |
|
2025
Q1 | $3.82M | Buy |
88,233
+5,596
| +7% | +$242K | 0.01% | 1283 |
|
2024
Q4 | $4.64M | Sell |
82,637
-9,312
| -10% | -$523K | 0.01% | 1074 |
|
2024
Q3 | $6.26M | Sell |
91,949
-71,892
| -44% | -$4.9M | 0.01% | 898 |
|
2024
Q2 | $6.92M | Buy |
163,841
+56,174
| +52% | +$2.37M | 0.02% | 827 |
|
2024
Q1 | $7.44M | Buy |
107,667
+54,632
| +103% | +$3.77M | 0.02% | 785 |
|
2023
Q4 | $3.92M | Buy |
53,035
+7,536
| +17% | +$558K | 0.03% | 523 |
|
2023
Q3 | $3.1M | Buy |
45,499
+1,219
| +3% | +$83.2K | 0.03% | 583 |
|
2023
Q2 | $4.16M | Buy |
44,280
+345
| +0.8% | +$32.4K | 0.04% | 472 |
|
2023
Q1 | $2.98M | Sell |
43,935
-3,668
| -8% | -$249K | 0.03% | 577 |
|
2022
Q4 | $2.36M | Buy |
47,603
+21,705
| +84% | +$1.07M | 0.02% | 643 |
|
2022
Q3 | $841K | Sell |
25,898
-876
| -3% | -$28.4K | 0.02% | 792 |
|
2022
Q2 | $1.06M | Sell |
26,774
-733
| -3% | -$28.9K | 0.02% | 771 |
|
2022
Q1 | $1.92M | Buy |
27,507
+1,732
| +7% | +$121K | 0.03% | 572 |
|
2021
Q4 | $2.01M | Buy |
25,775
+4,093
| +19% | +$319K | 0.03% | 555 |
|
2021
Q3 | $2.07M | Buy |
21,682
+1,260
| +6% | +$120K | 0.03% | 509 |
|
2021
Q2 | $2.54M | Buy |
20,422
+12,443
| +156% | +$1.55M | 0.04% | 437 |
|
2021
Q1 | $1.05M | Sell |
7,979
-10,040
| -56% | -$1.32M | 0.02% | 658 |
|
2020
Q4 | $2.39M | Buy |
+18,019
| New | +$2.39M | 0.05% | 386 |
|